Bharat Immunologicals & Biologicals Corporation Limited (BOM:524663)

India flag India · Delayed Price · Currency is INR
17.33
+0.41 (2.42%)
At close: Mar 10, 2026
Market Cap748.31M -13.1%
Revenue (ttm)76.50M -90.0%
Net Income-184.83M
EPS-4.28
Shares Out43.18M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,102
Average Volume19,459
Open18.00
Previous Close16.92
Day's Range16.70 - 18.00
52-Week Range15.80 - 28.80
Beta0.17
RSI40.23
Earnings DateOct 31, 2025

About BOM:524663

Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, engages in the manufacture and sale of pharmaceutical products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, and BIB sweet tablets. The company was incorporated in 1989 and is based in Bulandshahr, India. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1989
Country India
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524663
Full Company Profile

Financial Performance

In fiscal year 2023, BOM:524663's revenue was 446.09 million, a decrease of -43.09% compared to the previous year's 783.88 million. Losses were -166.39 million, 90.1% more than in 2022.

Financial Statements